These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10222364)

  • 21. Stabilization of homocysteine concentration in whole blood.
    Probst R; Brandl R; Blümke M; Neumeier D
    Clin Chem; 1998 Jul; 44(7):1567-9. PubMed ID: 9665444
    [No Abstract]   [Full Text] [Related]  

  • 22. Hyperhomocysteinemia in patients with arterial occlusive disease.
    Aksoy M; Basar Y; Salmayenli N; Ayalp K; Genc FA; Dilege S; Kayabali M; Baktiroglu S; Kurtoglu M
    Surg Today; 2006; 36(4):327-31. PubMed ID: 16554989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance.
    Boers GH
    Thromb Haemost; 1997 Jul; 78(1):520-2. PubMed ID: 9198207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An alternative view of homocysteine.
    Dudman NP
    Lancet; 1999 Dec; 354(9195):2072-4. PubMed ID: 10636386
    [No Abstract]   [Full Text] [Related]  

  • 25. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease.
    Tsakiris DA; Tschöpl M; Jäger K; Haefeli WE; Wolf F; Marbet GA
    Atherosclerosis; 1999 Jan; 142(1):193-200. PubMed ID: 9920521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
    Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years.
    Boers GH; Smals AG; Trijbels FJ; Leermakers AI; Kloppenborg PW
    J Clin Invest; 1983 Dec; 72(6):1971-6. PubMed ID: 6643682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease.
    Boers GH; Smals AG; Trijbels FJ; Fowler B; Bakkeren JA; Schoonderwaldt HC; Kleijer WJ; Kloppenborg PW
    N Engl J Med; 1985 Sep; 313(12):709-15. PubMed ID: 4033695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review.
    Malinow MR
    Clin Chem; 1995 Jan; 41(1):173-6. PubMed ID: 7813076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genotypes and haplotypes and plasma homocysteine levels in patients with occlusive artery disease and deep venous thrombosis.
    Spiroski I; Kedev S; Antov S; Arsov T; Krstevska M; Dzhekova-Stojkova S; Bosilkova G; Kostovska S; Trajkov D; Petlichkovski A; Strezova A; Efinska-Mladenovska O; Spiroski M
    Acta Biochim Pol; 2008; 55(3):587-94. PubMed ID: 18800176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial marker proteins in hyperhomocysteinemia.
    de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ
    Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical risk factors for cardiovascular disease in an aged male population: emerging vascular pathogens.
    Lippi G; Arosio E; Prior M; Guidi G
    Angiology; 2001 Oct; 52(10):681-7. PubMed ID: 11666132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skin surface oxygen pressure in healthy volunteers and patients with arterial occlusive disease.
    Creutzig A; Caspary L; Alexander K
    Int J Microcirc Clin Exp; 1991 Aug; 10(3):231-40. PubMed ID: 1955281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma homocyst(e)ine: a risk factor for arterial occlusive diseases.
    Malinow MR
    J Nutr; 1996 Apr; 126(4 Suppl):1238S-43S. PubMed ID: 8642463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hyperhomocysteinemia, a risk factor for atherosclerosis: causes and effects].
    Weiss N; Pietrzik K; Keller C
    Dtsch Med Wochenschr; 1999 Sep; 124(38):1107-13. PubMed ID: 10535040
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of age and sex on plasma total homocysteine in Taiwanese subjects.
    Chou ST; Ko LE; Lim PS; Huang JL; Yang CS
    Chin J Physiol; 2000 Dec; 43(4):159-64. PubMed ID: 11292180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating homocysteine and large arterial stiffness and thickness in a population-based sample of middle-aged and elderly men.
    Nakhai-Pour HR; Grobbee DE; Bots ML; Muller M; van der Schouw YT
    J Hum Hypertens; 2007 Dec; 21(12):942-8. PubMed ID: 17597801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homocysteine measurements in geriatric patients.
    Raeder S; Landaas S; Laake K; Lyberg T; Engedal K
    Scand J Clin Lab Invest; 2006; 66(4):309-15. PubMed ID: 16777759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma total homocysteine concentrations in a Turkish population sample.
    Yaman H; Akgul EO; Kurt YG; Cakir E; Gocgeldi E; Kunak ZI; Macit E; Cayci T; Erbil MK
    Acta Cardiol; 2009 Apr; 64(2):247-51. PubMed ID: 19476119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Betaine in wine: answer to the French paradox?
    Mar MH; Zeisel SH
    Med Hypotheses; 1999 Nov; 53(5):383-5. PubMed ID: 10616037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.